UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 22, 2008
Ardea Biosciences, Inc.
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
| Delaware
|
|
1-33734
|
|
94-3200380 |
|
|
|
|
|
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.) |
| |
|
|
4939 Directors Place
San Diego, California
(Address of principal executive offices)
|
|
92121
(Zip Code) |
Registrant’s telephone number, including area code: (858) 652-6500
N/A
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
|
|
|
| o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
|
| o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
| o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
| o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
|
|
| Item 7.01. |
|
Regulation FD Disclosure |
A copy of the materials presented at the Company’s 2008 annual stockholders meeting and from time
to time thereafter is filed as Exhibit 99.1 hereto. The Company does not intend to file any update
of these presentation materials. The fact that these presentation materials are being furnished
should not be deemed an admission as to the materiality of any information contained in the
materials.
The information in this Item 7.01 and Exhibit 99.1 attached hereto shall not be deemed “filed” for
purposes of Section 18 of the Securities Exchange Act of 1934, nor shall such information be deemed
incorporated by reference in any filing under the Securities Act of 1933, except as shall be
expressly set forth by specific reference in such filing.
|
|
|
| Item 9.01. |
|
Financial Statements and Exhibits. |
| (d) |
|
Exhibits. The following material is filed as an exhibit to this Current Report on Form 8-K: |
| |
|
|
|
|
| Exhibit Number |
|
Document Description |
| |
99.1 |
|
|
Ardea Biosciences, Inc. presentation materials used at
the Company’s 2008 annual stockholders meeting and from
time to time thereafter. |